A Network Model for Early Clinical Development

Early clinical development (ECD) studies have become increasingly expensive in recent years. One approach to reducing timelines is the design and execution of hybrid clinical trial models in ECD studies, in which both healthy volunteers and patient populations participate. This approach, which is suitable for both small-molecule drugs and biologics (including biosimilars), allows sponsors to begin tracking the impact of their drug on the targeted population to more rapidly confirm early proof of concept. This white paper discusses lessons learned based on IQVIA’s experience with a vast number of ECD studies across the Asia-Pacific region, Europe, and the United States.

Patient Recruitment

Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.

Clinical Trials

Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.

Clinical Research & Development Solutions

Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.

To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Related solutions